Company currently initiating additional trial sites and working with study investigators to enroll participants IMNN-001 is the first and only immunotherapy to show meaningful overall survival benefit ...

Company currently initiating additional trial sites and working with study investigators to enroll participants IMNN-001 is the first and only immunotherapy to show meaningful overall survival benefit ...

Negative Breast Cancer Market Insight, Epidemiology and Market Forecast - 2035" report delivers comprehensive insights into triple-negative breast cancer, i ...

These pathological consequences are amplified in the context of mutations in repair-related genes like BRCA1 and BRCA2, underlining their relevance in diseases such as cancer and neurodegeneration.

Germline mutations in the BRCA1 gene increase the lifetime risk of breast cancer to as high as 80%. Preventive measures and early detection strategies remain limited, largely due to an incomplete ...

Genetic tests are needed to establish whether your cancer has the specific genetic mutations, including BRCA mutations ... Bone metastases of prostate cancer: Molecular mechanisms, targeted diagnosis ...

A person with mCRPC who has a BRCA mutation may be able to get a PARP inhibitor ... Chandrasekar T, Yang JC, Gao AC, et al. Mechanisms of resistance in castration-resistant prostate cancer (CRPC).